
Paperplane Therapeutics
Paperplane Therapeutics develops clinically validated digital therapeutics that use immersive virtual reality and cognitive behavioral therapy to reduce pain and anxiety in medical settings. Designed for patients aged 5 and up, its solutions are deployed across outpatient procedures, imaging, dental care, and perioperative workflows. Built in collaboration with healthcare providers, Paperplane’s platform enhances patient comfort, shortens treatment cycles, and improves clinical efficiency—delivering measurable value to both patients and providers.
Company Type
Digital Therapeutics
Leadership
Jean-Simon Fortin, MD: CEO
Year Invested
2024